Latest News about REGN
Recent news which mentions REGN
   Why This Pfizer, Regeneron Analyst Has Contrasting Recommendations For The COVID Stock Plays
   
  
  
  January 05, 2022
  From Benzinga
 
   Benzinga's Top Ratings Upgrades, Downgrades For January 5, 2022
   
  
  
  January 05, 2022
  From Benzinga
 
   3 Healthcare Stocks That Could Rocket Higher in 2022
   
  
  
  January 04, 2022
  From Motley Fool
 
   Benzinga's Top Ratings Upgrades, Downgrades For January 3, 2022
   
  
  
  January 03, 2022
  From Benzinga
 
   Better Buy: CRISPR vs. Intellia
   
  
  
  January 03, 2022
  From Motley Fool
 
   Attention Biotech Investors: Mark Your Calendar For January PDUFA Dates
   
  
  
  December 31, 2021
  From Benzinga
 
   Two Paths to End the Pandemic but the Hybrid Approach Looks Dominant
   
  
  
  December 29, 2021
  From Benzinga
 
   AstraZeneca's COVID-19 Antibody Effective Against Omicron Variant
   
  
  
  December 16, 2021
  From Benzinga
 
   Benzinga's Top Ratings Upgrades, Downgrades For December 15, 2021
   
  
  
  December 15, 2021
  From Benzinga
 
   2 No-Brainer Healthcare Stocks to Buy Right Now
   
  
  
  December 13, 2021
  From Motley Fool
 
   Novartis Reveals Two Year Results From Beovu Trial In Diabetic Macular Edema Patients
   
  
  
  December 09, 2021
  From Benzinga
 
   Benzinga's Top Ratings Upgrades, Downgrades For December 9, 2021
   
  
  
  December 09, 2021
  From Benzinga
 
   Vir, GSK’s COVID-19 antibody treatment works against omicron in a lab study, and WHO no longer recommends convalescent plasma
   
  
  
  December 07, 2021
  From MarketWatch
 
   2 Big Stock Bets That Are Insiders Are Buying Now
   
  
  
  December 06, 2021
  From InvestorPlace
 
   Benzinga's Top Ratings Upgrades, Downgrades For December 6, 2021
   
  
  
  December 06, 2021
  From Benzinga
 
   The Week Ahead In Biotech (Dec. 6-Dec. 11): Daré FDA Decision, Adcom Tryst For Reata, Multiple Conference Presentations And More
   
  
  
  December 06, 2021
  From Benzinga
 
   Regeneron: Surfing on Covid, With More Under the Surface
   
  
  
  December 02, 2021
  From InvestorPlace
 
   Why Are Stocks Down Today? 4 Things to Know.
   
  
  
  November 30, 2021
  From InvestorPlace
 
   HC Wainwright Sees 'Buying Opportunity' For This COVID-19 Antibody Stock After Sell-Off
   
  November 30, 2021
  Tickers 
   REGN
  
  
  From Benzinga
 
   7 Drug Stocks to Buy Now While They’re Still on Sale
   
  
  
  November 30, 2021
  From InvestorPlace
 From MarketWatch
 
   WHO urges calm approach to omicron variant of COVID, warns travel restrictions may undermine surveillance and tracking
   
  
  
  November 30, 2021
  From MarketWatch
 
   Retail Stocks Trading Lower on Weaker Black Friday Numbers
   
  
  
  November 30, 2021
  From Benzinga
 
   The Daily Biotech Pulse: Cumberland Jumps On FDA Nod, Regeneron Says Antibody Treatment May Be Less Effective Against Omicron, ImmunoGen Readout
   
  
  
  November 30, 2021
  From Benzinga
 
   JPMorgan’s S&P 500 forecast for 2022 is among the most bullish on Wall Street. Here’s the biggest risk it sees for stocks.
   
  
  
  November 30, 2021
  From MarketWatch
 
   ADGI Stock Soars as Analysts Lock On to Its Omicron-Fighting Potential
   
  
  
  November 29, 2021
  From InvestorPlace
 From Benzinga
 
   Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
  
  
 Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
  © 2025 FinancialContent. All rights reserved.
 
